Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Sep 30;311(7009):844–846. doi: 10.1136/bmj.311.7009.844

Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials.

R L Aspinall 1, N W Goodman 1
PMCID: PMC2550853  PMID: 7580491

Abstract

OBJECTIVE--To determine how many patients were deprived of treatment by being given placebo as comparator in trials of ondansetron for postoperative nausea and vomiting. DESIGN--Review of published trials of ondansetron during 1991 to July 1994. SETTING--Medline search in a university department of anaesthesia. SUBJECTS--8806 patients who had been included in 18 indexed placebo controlled trials of ondansetron as prophylaxis against or treatment of postoperative nausea and vomiting. RESULTS--Five studies (1236 patients) had been published by July 1992. All were placebo controlled trials. By July 1994, 8806 patients had been included in 18 indexed placebo controlled studies of prophylaxis or treatment. Only 462 patients had been in studies that compared ondansetron with other drugs, and there were no indexed comparative trials of treatment of nausea and vomiting. Roughly 2180 patients had been given placebo as prophylaxis and 440 had been given placebo when already experiencing postoperative nausea or vomiting. CONCLUSIONS--Around 2620 patients in the reviewed studies were denied existing drugs, which, though not completely effective or without side effects, do bring some relief from postoperative nausea and vomiting. Drug regulatory bodies should collaborate with drug companies to ensure better comparison of new with established drugs. This would avoid placebos being given to more than the fewest patients necessary to confirm effect and would allow doctors to be informed more quickly about relative efficacies.

Full text

PDF
844

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alon E., Himmelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth Analg. 1992 Oct;75(4):561–565. doi: 10.1213/00000539-199210000-00017. [DOI] [PubMed] [Google Scholar]
  2. Bero L. A., Galbraith A., Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23;271(8):612–617. [PubMed] [Google Scholar]
  3. Bero L. A., Galbraith A., Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med. 1992 Oct 15;327(16):1135–1140. doi: 10.1056/NEJM199210153271606. [DOI] [PubMed] [Google Scholar]
  4. Bodner M., White P. F. Antiemetic efficacy of ondansetron after outpatient laparoscopy. Anesth Analg. 1991 Sep;73(3):250–254. doi: 10.1213/00000539-199109000-00003. [DOI] [PubMed] [Google Scholar]
  5. Bogod D. G. The postpartum stomach--when is it safe? Anaesthesia. 1994 Jan;49(1):1–2. doi: 10.1111/j.1365-2044.1994.tb03301.x. [DOI] [PubMed] [Google Scholar]
  6. Bouly A., Nathan N., Feiss P. Prévention des nausées et vomissements postopératoires par l'ondansétron. Ann Fr Anesth Reanim. 1992;11(5):496–501. doi: 10.1016/s0750-7658(05)80754-3. [DOI] [PubMed] [Google Scholar]
  7. Böhrer H., Bach A., Martin E. Ondansetron--Ein neues anästhesierelevantes Antiemetikum? Anaesthesiol Reanim. 1994;19(1):11–13. [PubMed] [Google Scholar]
  8. Claybon L. Single dose intravenous ondansetron for the 24-hour treatment of postoperative nausea and vomiting. Anaesthesia. 1994 Jan;49 (Suppl):24–29. doi: 10.1111/j.1365-2044.1994.tb03579.x. [DOI] [PubMed] [Google Scholar]
  9. Dershwitz M., Rosow C. E., Di Biase P. M., Joslyn A. F., Sanderson P. E. Ondansetron is effective in decreasing postoperative nausea and vomiting. Clin Pharmacol Ther. 1992 Jul;52(1):96–101. doi: 10.1038/clpt.1992.107. [DOI] [PubMed] [Google Scholar]
  10. Du Pen S., Scuderi P., Wetchler B., Sung Y. F., Mingus M., Clayborn L., Leslie J., Talke P., Apfelbaum J., Sharifi-Azad S. Ondansetron in the treatment of postoperative nausea and vomiting in ambulatory outpatients: a dose-comparative, stratified, multicentre study. Eur J Anaesthesiol Suppl. 1992 Nov;6:55–62. [PubMed] [Google Scholar]
  11. Dupeyron J. P., Conseiller C., Levarlet M., Hemmingsen C., Schoeffler P., Pedersen F. M., Gribomont B., Kaplan L. A. The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. Anaesthesia. 1993 Mar;48(3):214–218. doi: 10.1111/j.1365-2044.1993.tb06904.x. [DOI] [PubMed] [Google Scholar]
  12. Gan T. J., Collis R., Hetreed M. Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. Br J Anaesth. 1994 May;72(5):544–547. doi: 10.1093/bja/72.5.544. [DOI] [PubMed] [Google Scholar]
  13. Hardy J. F. Vaporizer overfilling. Can J Anaesth. 1993 Jan;40(1):1–3. doi: 10.1007/BF03009308. [DOI] [PubMed] [Google Scholar]
  14. Helmers J. H. Oral ondansetron in the prevention of postoperative nausea and vomiting. Eur J Anaesthesiol Suppl. 1992 Nov;6:49–54. [PubMed] [Google Scholar]
  15. Herxheimer A., Collier J. Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation. BMJ. 1990 Feb 3;300(6720):307–311. doi: 10.1136/bmj.300.6720.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Isal J. P., Haigh C. G., Hellstern K., Inall F. C., Joslyn A. F., Kanarek B. K., Kaplan L. A., Povey P. M. The clinical development of ondansetron for use in the prevention and treatment of postoperative nausea and vomiting. Eur J Anaesthesiol Suppl. 1992 Nov;6:33–36. [PubMed] [Google Scholar]
  17. Joslyn A. F. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions. Anaesthesia. 1994 Jan;49 (Suppl):34–37. doi: 10.1111/j.1365-2044.1994.tb03581.x. [DOI] [PubMed] [Google Scholar]
  18. Kaufmann M. A., Rosow C., Schnieper P., Schneider M. Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide, and tropisetron. Anesth Analg. 1994 May;78(5):988–994. doi: 10.1213/00000539-199405000-00027. [DOI] [PubMed] [Google Scholar]
  19. Kenny G. N., Oates J. D., Leeser J., Rowbotham D. J., Lip H., Rust M., Saur P., Onsrud M., Haigh C. G. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth. 1992 May;68(5):466–470. doi: 10.1093/bja/68.5.466. [DOI] [PubMed] [Google Scholar]
  20. Larijani G. E., Gratz I., Afshar M., Minassian S. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo. Anesth Analg. 1991 Sep;73(3):246–249. [PubMed] [Google Scholar]
  21. Leeser J., Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist. Anesth Analg. 1991 Jun;72(6):751–755. doi: 10.1213/00000539-199106000-00005. [DOI] [PubMed] [Google Scholar]
  22. Litman R. S., Wu C. L., Catanzaro F. A. Ondansetron decreases emesis after tonsillectomy in children. Anesth Analg. 1994 Mar;78(3):478–481. doi: 10.1213/00000539-199403000-00010. [DOI] [PubMed] [Google Scholar]
  23. Malins A. F., Field J. M., Nesling P. M., Cooper G. M. Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide and placebo. Br J Anaesth. 1994 Feb;72(2):231–233. doi: 10.1093/bja/72.2.231. [DOI] [PubMed] [Google Scholar]
  24. McKenzie R., Kovac A., O'Connor T., Duncalf D., Angel J., Gratz I., Tolpin E., McLeskey C., Joslyn A. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology. 1993 Jan;78(1):21–28. doi: 10.1097/00000542-199301000-00005. [DOI] [PubMed] [Google Scholar]
  25. McKenzie R., Sharifi-Azad S., Dershwitz M., Miguel R., Joslyn A. F., Tantisira B., Rosenblum F., Rosow C. E., Downs J. B., Bowie J. R. A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients. J Clin Anesth. 1993 Jan-Feb;5(1):30–36. doi: 10.1016/0952-8180(93)90084-r. [DOI] [PubMed] [Google Scholar]
  26. Pearman M. H. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia. 1994 Jan;49 (Suppl):11–15. doi: 10.1111/j.1365-2044.1994.tb03577.x. [DOI] [PubMed] [Google Scholar]
  27. Raphael J. H., Norton A. C. Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide. Br J Anaesth. 1993 Dec;71(6):845–848. doi: 10.1093/bja/71.6.845. [DOI] [PubMed] [Google Scholar]
  28. Rochon P. A., Gurwitz J. H., Cheung C. M., Hayes J. A., Chalmers T. C. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994 Jul 13;272(2):108–113. [PubMed] [Google Scholar]
  29. Rothman K. J., Michels K. B. The continuing unethical use of placebo controls. N Engl J Med. 1994 Aug 11;331(6):394–398. doi: 10.1056/NEJM199408113310611. [DOI] [PubMed] [Google Scholar]
  30. Rust M., Cohen L. A. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. The European and US Study Groups. Anaesthesia. 1994 Jan;49 (Suppl):16–23. doi: 10.1111/j.1365-2044.1994.tb03578.x. [DOI] [PubMed] [Google Scholar]
  31. Scuderi P., Wetchler B., Sung Y. F., Mingus M., DuPen S., Claybon L., Leslie J., Talke P., Apfelbaum J., Sharifi-Azad S. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology. 1993 Jan;78(1):15–20. doi: 10.1097/00000542-199301000-00004. [DOI] [PubMed] [Google Scholar]
  32. Sung Y. F., Wetchler B. V., Duncalf D., Joslyn A. F. A double-blind, placebo-controlled pilot study examining the effectiveness of intravenous ondansetron in the prevention of postoperative nausea and emesis. J Clin Anesth. 1993 Jan-Feb;5(1):22–29. doi: 10.1016/0952-8180(93)90083-q. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES